Suitable Technology for Each Active Substance

Whether the bio-availability need to be optimized or side effects need to be decreased.  Whether life cycles of established successful products need to be extended or the patient compliance needs to be improved: LTS develops innovative technologies to existing drugs that are precisely tailored to the needs of each active ingredient.

With the transdermal Therapeutic System (TTS) and the oral drug films, the so-called wafers, LTS has developed two systems that are leaders in their fields.

Our objective and the future aims of our customers stand at the beginning of each new technology. On this basis we provide for the desired active ingredient, a solution which consists of a specially developed technology. Recent examples are the "self-destructive" transdermal patch and gastroretentive systems.